-
1
Upregulation of CD19 by low‐dose chidamide promotes CAR T cells functionality in B-cell non-Hodgkin lymphoma
Published 2025-01-01Subjects: Get full text
Article -
2
Knockout IL4I1 affects macrophages to improve poor efficacy of CD19 CAR-T combined with PD-1 inhibitor in relapsed/refractory diffuse large B-cell lymphoma
Published 2025-01-01Subjects: “…CD19 CAR-T…”
Get full text
Article -
3